BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17001312)

  • 21. Association between suppressors of cytokine signalling, T-helper type 1/T-helper type 2 balance and allergic sensitization in children.
    Daegelmann C; Herberth G; Röder S; Herbarth O; Giese T; Krämer U; Behrendt H; Borte M; Heinrich J; Emmrich F; Lehmann I;
    Clin Exp Allergy; 2008 Mar; 38(3):438-48. PubMed ID: 18167120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
    Sasi W; Jiang WG; Sharma A; Mokbel K
    BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressor of cytokine signalling gene expression is elevated in breast carcinoma.
    Raccurt M; Tam SP; Lau P; Mertani HC; Lambert A; Garcia-Caballero T; Li H; Brown RJ; McGuckin MA; Morel G; Waters MJ
    Br J Cancer; 2003 Aug; 89(3):524-32. PubMed ID: 12888825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of SOCS is altered in rheumatoid arthritis.
    Isomäki P; Alanärä T; Isohanni P; Lagerstedt A; Korpela M; Moilanen T; Visakorpi T; Silvennoinen O
    Rheumatology (Oxford); 2007 Oct; 46(10):1538-46. PubMed ID: 17726036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
    Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
    Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney disease.
    Rastmanesh MM; Bluyssen HA; Joles JA; Boer P; Willekes N; Braam B
    Eur J Pharmacol; 2008 Sep; 593(1-3):99-104. PubMed ID: 18656467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Favorable prognostic value of SOCS2 and IGF-I in breast cancer.
    Haffner MC; Petridou B; Peyrat JP; Révillion F; Müller-Holzner E; Daxenbichler G; Marth C; Doppler W
    BMC Cancer; 2007 Jul; 7():136. PubMed ID: 17651480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1.
    Zhuang D; Qiu Y; Haque SJ; Dong F
    J Leukoc Biol; 2005 Oct; 78(4):1008-15. PubMed ID: 16033816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy.
    Fitzgerald JS; Toth B; Jeschke U; Schleussner E; Markert UR
    J Reprod Immunol; 2009 Dec; 83(1-2):117-23. PubMed ID: 19853926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells.
    Liu X; Mameza MG; Lee YS; Eseonu CI; Yu CR; Kang Derwent JJ; Egwuagu CE
    Diabetes; 2008 Jun; 57(6):1651-8. PubMed ID: 18356406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
    Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
    J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOCS: physiological suppressors of cytokine signaling.
    Krebs DL; Hilton DJ
    J Cell Sci; 2000 Aug; 113 ( Pt 16)():2813-9. PubMed ID: 10910765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells.
    Lesinski GB; Zimmerer JM; Kreiner M; Trefry J; Bill MA; Young GS; Becknell B; Carson WE
    BMC Cancer; 2010 Apr; 10():142. PubMed ID: 20398276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour-promoting role of SOCS1 in colorectal cancer cells.
    Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
    Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway.
    Pothlichet J; Chignard M; Si-Tahar M
    J Immunol; 2008 Feb; 180(4):2034-8. PubMed ID: 18250407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages.
    Cheng C; Huang C; Ma TT; Bian EB; He Y; Zhang L; Li J
    Toxicol Lett; 2014 Mar; 225(3):488-97. PubMed ID: 24440346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells.
    Bluyssen HA; Rastmanesh MM; Tilburgs C; Jie K; Wesseling S; Goumans MJ; Boer P; Joles JA; Braam B
    Am J Physiol Cell Physiol; 2010 Aug; 299(2):C354-62. PubMed ID: 20484656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy.
    Francipane MG; Eterno V; Spina V; Bini M; Scerrino G; Buscemi G; Gulotta G; Todaro M; Dieli F; De Maria R; Stassi G
    Cancer Res; 2009 Aug; 69(15):6141-8. PubMed ID: 19638576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells.
    Monni R; Santos SC; Mauchauffe M; Berger R; Ghysdael J; Gouilleux F; Gisselbrecht S; Bernard O; Penard-Lacronique V
    Oncogene; 2001 Feb; 20(7):849-58. PubMed ID: 11314018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.